Gilead (GILD) Harvoni+Sovaldi TRx Up 3% (WoW); AbbVie (ABBV) Viekira Pak TRx Down 19% - RBC, Citing IMS
Get Alerts GILD Hot Sheet
Price: $67.03 +0.12%
Rating Summary:
24 Buy, 16 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
24 Buy, 16 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) Harvoni TRx for the week ending November 20 was up 3% to 6882, according to RBC, citing data from IMS. NRx was 2605, down 2% week-over-week. Harvoni+Sovaldi TRx was 8861, up 3% week-over-week. Harvoni+Sovaldi NRx was 3281, down 2%.
AbbVie (NYSE: ABBV) Viekira Pak TRx was 470, down 19%, and NRx was 174, down 31%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Company (SAM) PT Lowered to $325 at Jefferies
- Spotify (SPOT) PT Raised to $345 at Macquarie
- Fiserv (FI) PT Raised to $200 at Evercore ISI
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!